Compare Ishares Msci Spain ETF (EWP) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Spain ETF vs GeneDx Holdings Corp — how do they compare? Ishares Msci Spain ETF trades at $57.9 (market cap $2.30B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Ishares Msci Spain ETF and GeneDx Holdings Corp are close in size by market cap, and Ishares Msci Spain ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Spain ETF for 41 Days and GeneDx Holdings Corp for 19 Days on average.
| EWP | WGS | |
|---|---|---|
Market Cap | $2.30B | $2.02B |
Volume | 845,747 | 734,640 |
Sector | Broad Market / Factor | Health |
52-Week High | $63.23 | $167.51 |
52-Week Low | $48.33 | $34.51 |
Typical Hold Time | 41 Days | 19 Days |
Enterprise Value | — | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWP, the iShares MSCI Spain ETF, trades at $57.90 with minimal daily movement (+0.14%). Technical indicators show a bearish trend with strong selling pressure across moving averages and oscillators. The ETF offers exposure to Spanish equities at a discounted valuation with a 2.7% yield, though concentrated in financials and utilities. Recent ECB rate hikes and energy price volatility create macroeconomic headwinds for European markets.
The outlook remains cautious given bearish technical signals and eurozone economic pressures. Attractive valuation and dividend yield provide support, but concentration risk and monetary policy tightening pose challenges. Further upside depends on Spanish economic resilience and stabilization of energy inflation.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ishares Msci Spain ETF
EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
